Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2011 | 05-2011 | 02-2011 | 11-2010 | 08-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10 | 4 | 20 | 1 | 10 |
| Other current assets | 0 | 5 | 0 | 9 | 0 |
| TOTAL | $10 | $9 | $20 | $10 | $10 |
| Non-Current Assets | |||||
| PPE Net | N/A | 20 | 20 | 20 | 20 |
| TOTAL | $N/A | $20 | $20 | $20 | $20 |
| Total Assets | $10 | $10 | $30 | $10 | $10 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 140 | 170 | 140 | 140 | 130 |
| Accrued Expenses | 60 | 60 | 50 | 50 | 40 |
| TOTAL | $660 | $710 | $290 | $270 | $250 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 360 | 360 | 360 |
| TOTAL | $N/A | $N/A | $360 | $360 | $360 |
| Total Liabilities | $660 | $710 | $660 | $630 | $610 |
| Shareholders' Equity | |||||
| Common Shares | 50 | 40 | 190 | 190 | 180 |
| Retained earnings | -58,050 | -58,000 | -57,920 | -57,870 | -57,810 |
| Other shareholders' equity | 10 | 10 | 0 | 10 | 10 |
| TOTAL | $-640 | $-700 | $-630 | $-620 | $-590 |
| Total Liabilities And Equity | $20 | $10 | $30 | $10 | $20 |